FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions
horizonal rule
Dockets Management

Up | AC Home Page

Food and Drug Administration

Risk Communication Advisory Committee

August 14-15, 2008

SLIDES

FDA

Introductory Remarks:  Objective of Meeting, Baruch Fischhoff, Ph.D (pdf) (ppt)

Introductory Remarks:  FDA’s Communication and Concerns, Nancy M. Ostrove, Ph.D. (pdf) (ppt)

Non-Persuasive and Persuasive Communication:  What does FDA do?  What knowledge is needed? Panel of FDA Speakers from the Centers, listed individually below (pdf) (ppt)

[Lynne Rice, Director, Office of Communication, Education, and Radiation Programs, Center for Devices and Radiological Health; Paul Seligman, M.D., M.P.H., Associate Center Director for Safety Policy and Communication, Center for Drug Evaluation and Research; Lorrie McNeill, Director, Office of Communication, Training, and Manufacturers Assistance, Center for Biologics Evaluation and Research; Marjorie Davidson, Ph.D., Education Team Leader, Center for Food Safety and Applied Nutrition]

Laura Alvey Director for the Office of Communications, Center for Veterinary Medicine  (spoke between McNeill and Davidson, but slides are in separate file) (pdf) (ppt)

Non-Persuasive Communication:  What do we know? How do we know it?, Baruch Fischhoff, Ph.D. (pdf) (ppt)

Non-Persuasive Communication:  What do we know? How do we know it?  Ellen Peters, Ph.D. (pdf) (ppt)

Open Public Hearing:  William Maisel, MD, for Heart Rhythm Society (pdf) (ppt)

Persuasive Communication:  What do we know? How do we know it? Christine Bruhn, Ph.D. (pdf) (ppt)

Persuasive Communication:  What do we know? How do we know it?  Linda Neuhauser, Dr.P.H., M.P.H. (pdf) (ppt)

Urgent, Crisis or other Explanatory Communication in Practice:  How is it done and how is it evaluated? AnnaMaria DeSalva (reformatted to fit screen) (pdf) (ppt)

Urgent, Crisis or other Explanatory Communication in Practice:  How is it done and how is it evaluated? John Paling, Ph.D. (pdf) (ppt)

FDA Press:  Factors in Decisions on Communication about FDA Actions, Heidi Rebello, Deputy Assistant Commissioner for Public Affairs (pdf) (ppt)

Up | AC Home Page

Page last updated August 18, 2008 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management